USPSTF: Stand-Alone HPV Testing Recommended as Cervical Cancer Screening Option

13:34 EDT 21 Aug 2018 | NEJM

Women aged 30 to 65 years can now choose primary high-risk human papillomavirus (hrHPV) testing as an option for cervical cancer screening, according to...

More From BioPortfolio on "USPSTF: Stand-Alone HPV Testing Recommended as Cervical Cancer Screening Option"